Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

Kochupurackal P. Mohanakumar, Dhanasekharan Muralikrishnan, Bobby Thomas

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

The potent dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to produce hydroxyl radicals (OH) in vitro and in vivo. Salicylate (SA) can hydroxylate itself to form 2,3- and 2,5-dihydroxybenzoic acid (DHBA) by utilizing OH. In the present study we investigated the OH scavenging action and neuroprotective effects, if any, of SA in mice treated with MPTP (30 mg/kg i.p. twice, 16 h apart). MPTP treatment resulted in in vivo generation of OH and nigral neuronal insult as evidenced by dopamine depletion in nucleus caudatus putamen (NCP). This also caused significant decrease in glutathione in substantia nigra (SN) and NCP. SA administration alone in mice did not affect total monoamine oxidase (MAO) or MAO-B activities of the mitochondrial fraction or the crude enzyme preparation from SN or NCP. Pre-treatment of these animals with SA (25-100 mg/kg, i.p.) resulted in dose-dependent production of 2,3- and 2,5-DHBA in NCP. SA administration prior to or following MPTP blocked the neurotoxin-induced behavioural dysfunction as well as glutathione and dopamine depletion on the 7th day indicating its potent neuroprotective action. The present study suggests that SA acts as a free radical scavenger in the brain and indicates its strength as a valuable neuroprotectant. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)281-290
Number of pages10
JournalBrain Research
Volume864
Issue number2
DOIs
StatePublished - May 12 2000

Fingerprint

Sodium Salicylate
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Salicylates
Caudate Nucleus
Putamen
Substantia Nigra
Monoamine Oxidase
Neurotoxins
Neuroprotective Agents
Glutathione
Dopamine
Free Radical Scavengers
Hydroxyl Radical
Neuroprotection
Brain
Enzymes

Keywords

  • Dopamine depletion
  • Free radical scavenger
  • Glutathione
  • Hydroxyl radicals
  • MPTP
  • Neuroprotection
  • Nucleus caudatus putamen
  • Salicylic acid

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. / Mohanakumar, Kochupurackal P.; Muralikrishnan, Dhanasekharan; Thomas, Bobby.

In: Brain Research, Vol. 864, No. 2, 12.05.2000, p. 281-290.

Research output: Contribution to journalArticle

Mohanakumar, Kochupurackal P. ; Muralikrishnan, Dhanasekharan ; Thomas, Bobby. / Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. In: Brain Research. 2000 ; Vol. 864, No. 2. pp. 281-290.
@article{992a9b67e45a4a928416e54157ff225d,
title = "Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity",
abstract = "The potent dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to produce hydroxyl radicals (OH) in vitro and in vivo. Salicylate (SA) can hydroxylate itself to form 2,3- and 2,5-dihydroxybenzoic acid (DHBA) by utilizing OH. In the present study we investigated the OH scavenging action and neuroprotective effects, if any, of SA in mice treated with MPTP (30 mg/kg i.p. twice, 16 h apart). MPTP treatment resulted in in vivo generation of OH and nigral neuronal insult as evidenced by dopamine depletion in nucleus caudatus putamen (NCP). This also caused significant decrease in glutathione in substantia nigra (SN) and NCP. SA administration alone in mice did not affect total monoamine oxidase (MAO) or MAO-B activities of the mitochondrial fraction or the crude enzyme preparation from SN or NCP. Pre-treatment of these animals with SA (25-100 mg/kg, i.p.) resulted in dose-dependent production of 2,3- and 2,5-DHBA in NCP. SA administration prior to or following MPTP blocked the neurotoxin-induced behavioural dysfunction as well as glutathione and dopamine depletion on the 7th day indicating its potent neuroprotective action. The present study suggests that SA acts as a free radical scavenger in the brain and indicates its strength as a valuable neuroprotectant. Copyright (C) 2000 Elsevier Science B.V.",
keywords = "Dopamine depletion, Free radical scavenger, Glutathione, Hydroxyl radicals, MPTP, Neuroprotection, Nucleus caudatus putamen, Salicylic acid",
author = "Mohanakumar, {Kochupurackal P.} and Dhanasekharan Muralikrishnan and Bobby Thomas",
year = "2000",
month = "5",
day = "12",
doi = "10.1016/S0006-8993(00)02189-2",
language = "English (US)",
volume = "864",
pages = "281--290",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

AU - Mohanakumar, Kochupurackal P.

AU - Muralikrishnan, Dhanasekharan

AU - Thomas, Bobby

PY - 2000/5/12

Y1 - 2000/5/12

N2 - The potent dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to produce hydroxyl radicals (OH) in vitro and in vivo. Salicylate (SA) can hydroxylate itself to form 2,3- and 2,5-dihydroxybenzoic acid (DHBA) by utilizing OH. In the present study we investigated the OH scavenging action and neuroprotective effects, if any, of SA in mice treated with MPTP (30 mg/kg i.p. twice, 16 h apart). MPTP treatment resulted in in vivo generation of OH and nigral neuronal insult as evidenced by dopamine depletion in nucleus caudatus putamen (NCP). This also caused significant decrease in glutathione in substantia nigra (SN) and NCP. SA administration alone in mice did not affect total monoamine oxidase (MAO) or MAO-B activities of the mitochondrial fraction or the crude enzyme preparation from SN or NCP. Pre-treatment of these animals with SA (25-100 mg/kg, i.p.) resulted in dose-dependent production of 2,3- and 2,5-DHBA in NCP. SA administration prior to or following MPTP blocked the neurotoxin-induced behavioural dysfunction as well as glutathione and dopamine depletion on the 7th day indicating its potent neuroprotective action. The present study suggests that SA acts as a free radical scavenger in the brain and indicates its strength as a valuable neuroprotectant. Copyright (C) 2000 Elsevier Science B.V.

AB - The potent dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to produce hydroxyl radicals (OH) in vitro and in vivo. Salicylate (SA) can hydroxylate itself to form 2,3- and 2,5-dihydroxybenzoic acid (DHBA) by utilizing OH. In the present study we investigated the OH scavenging action and neuroprotective effects, if any, of SA in mice treated with MPTP (30 mg/kg i.p. twice, 16 h apart). MPTP treatment resulted in in vivo generation of OH and nigral neuronal insult as evidenced by dopamine depletion in nucleus caudatus putamen (NCP). This also caused significant decrease in glutathione in substantia nigra (SN) and NCP. SA administration alone in mice did not affect total monoamine oxidase (MAO) or MAO-B activities of the mitochondrial fraction or the crude enzyme preparation from SN or NCP. Pre-treatment of these animals with SA (25-100 mg/kg, i.p.) resulted in dose-dependent production of 2,3- and 2,5-DHBA in NCP. SA administration prior to or following MPTP blocked the neurotoxin-induced behavioural dysfunction as well as glutathione and dopamine depletion on the 7th day indicating its potent neuroprotective action. The present study suggests that SA acts as a free radical scavenger in the brain and indicates its strength as a valuable neuroprotectant. Copyright (C) 2000 Elsevier Science B.V.

KW - Dopamine depletion

KW - Free radical scavenger

KW - Glutathione

KW - Hydroxyl radicals

KW - MPTP

KW - Neuroprotection

KW - Nucleus caudatus putamen

KW - Salicylic acid

UR - http://www.scopus.com/inward/record.url?scp=0034640430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034640430&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(00)02189-2

DO - 10.1016/S0006-8993(00)02189-2

M3 - Article

C2 - 10802035

AN - SCOPUS:0034640430

VL - 864

SP - 281

EP - 290

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -